Metformin-associated lactic acidosis: A prognostic and therapeutic study
Metformin-associated lactic acidosis: A prognostic and therapeutic study
复制标题
DOI:
10.1097/ccm.0b013e3181a02490
复制
发表时间:
2009-07-01
影响因子:
8.8
通讯作者:
Fourrier, Francois
中科院分区:
文献类型:
--
作者:
Seidowsky, Alexandre;Nseir, Saad;Fourrier, Francois
Objectives. Metformin-associated lactic acidosis is a rare and serious complication of biguanide treatment. It usually occurs when a precipitating disease induces an acute renal failure and an incidental overdose. Voluntary intoxication is rare. Bicarbonate hemodialysis (HD) is recommended to decrease metformin levels and correct acidosis but its optimal duration has not been determined. This study was designed to document the characteristics and prognostic factors of intentional and incidental metformin overdose and to determine the optimal duration of HD.Design: Ten years retrospective analysis of patients admitted in intensive care unit for metformin-associated lactic acidosis.Setting: Two intensive care units (50 beds) in a university hospital.Measurements and Main Results. Clinical and biological characteristics, organ failures, and sequential metformin levels during HD were recorded. Forty-two patients were included (13 voluntary intoxications and 29 incidental overdoses); 74% of patients were in acute renal failure and needed HD. No death was observed in intentional overdose patients compared with 48.3% mortality in incidental overdose patients. The factors significantly associated with mortality were logistic organ dysfunction system score, pH, plasma lactate, and prothrombin activity. By multivariate analysis, a prothrombin activity